Trade NNNN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Anbio Biotechnology Class A (NNNN) is trading at US$7.59, down 2.51% today as of Aug 28, 13:31 EDT. The company has a market capitalisation of US$298.9M. Over the past 52 weeks, NNNN has traded between US$6.61 and US$51.33. On Syfe you can trade NNNN with $0 commission and add it to your watchlist.
| Previous close | US$7.78 |
|---|---|
| Market cap | US$298.9M |
| 52-week range | US$6.61 – US$51.33 |
| Volume | 276.76K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Anbio Biotechnology Class A
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
Year: 2025
Anbio Biotechnology Files Mixed Shelf Registration
Jul 9, 9:52 PM · MT Newswires
Anbio Biotechnology Class A (NNNN) stock is trading at US$7.59, -2.51% from the previous close of US$7.78.
The market cap for Anbio Biotechnology Class A (NNNN) stock is approximately US$298.9M.
The 52-week high for Anbio Biotechnology Class A (NNNN) stock is US$51.33.
The 52-week low for Anbio Biotechnology Class A (NNNN) stock is US$6.61.
Anbio Biotechnology Class A (NNNN) does not currently pay a dividend.
Stay on top of NNNN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
